{"transactions":[{"id":5065,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:08.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":1175,"price":43.714,"value":51363.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $43.51 to $44.16.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":166025,"source":{"system":"sec-edgar","filing":"0001823563-26-000016","document":"wk-form4_1788566045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000016/wk-form4_1788566045.xml","form_type":"4"}},{"id":5064,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:08.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":2477,"price":42.8059,"value":106030.2143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $42.49 to $43.47.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":167200,"source":{"system":"sec-edgar","filing":"0001823563-26-000016","document":"wk-form4_1788566045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000016/wk-form4_1788566045.xml","form_type":"4"}},{"id":5063,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:08.000Z","date":"2026-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3603,"price":44.88,"value":161702.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and\ndoes not represent a sale."}],"balance_after":169677,"source":{"system":"sec-edgar","filing":"0001823563-26-000016","document":"wk-form4_1788566045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000016/wk-form4_1788566045.xml","form_type":"4"}},{"id":749313,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T01:38:40.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1961,"price":50.0913,"value":98229.0393,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $49.88 to $50.40.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":173280,"source":{"system":"sec-edgar","filing":"0001823563-26-000014","document":"wk-form4_1780623518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000014/wk-form4_1780623518.xml","form_type":"4"}},{"id":749312,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T01:38:40.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":49.2836,"value":78853.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $48.80 to $49.74.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":175241,"source":{"system":"sec-edgar","filing":"0001823563-26-000014","document":"wk-form4_1780623518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000014/wk-form4_1780623518.xml","form_type":"4"}},{"id":749311,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T01:38:40.000Z","date":"2026-06-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3693,"price":47.8,"value":176525.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and\ndoes not represent a sale."}],"balance_after":176841,"source":{"system":"sec-edgar","filing":"0001823563-26-000014","document":"wk-form4_1780623518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000014/wk-form4_1780623518.xml","form_type":"4"}},{"id":804248,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:51.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":140612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":140612,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":140612},"source":{"system":"sec-edgar","filing":"0001823563-26-000013","document":"form4-04212026_120444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000013/form4-04212026_120444.xml","form_type":"4"}},{"id":804247,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:51.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":140612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":140612},"source":{"system":"sec-edgar","filing":"0001823563-26-000013","document":"form4-04212026_120444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000013/form4-04212026_120444.xml","form_type":"4"}},{"id":850456,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:09:57.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":13157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":180534,"source":{"system":"sec-edgar","filing":"0001823563-26-000008","document":"wk-form4_1773176995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000008/wk-form4_1773176995.xml","form_type":"4"}},{"id":850455,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:09:57.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":36181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":167377,"source":{"system":"sec-edgar","filing":"0001823563-26-000008","document":"wk-form4_1773176995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000008/wk-form4_1773176995.xml","form_type":"4"}},{"id":855575,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T21:33:03.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":13941,"price":36.3288,"value":506459.8008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $36.01 to $36.55.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":131196,"source":{"system":"sec-edgar","filing":"0001823563-26-000006","document":"wk-form4_1772832781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000006/wk-form4_1772832781.xml","form_type":"4"}},{"id":855574,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T21:33:03.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":4400,"price":35.5476,"value":156409.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $35.00 to $35.99.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":145137,"source":{"system":"sec-edgar","filing":"0001823563-26-000006","document":"wk-form4_1772832781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000006/wk-form4_1772832781.xml","form_type":"4"}},{"id":860935,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:16:57.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7234,"price":36.01,"value":260496.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and\ndoes not represent a sale."}],"balance_after":149537,"source":{"system":"sec-edgar","filing":"0001823563-26-000004","document":"wk-form4_1772659015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000004/wk-form4_1772659015.xml","form_type":"4"}},{"id":873667,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:53:03.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":12049,"price":38.75,"value":466898.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale."}],"balance_after":156771,"source":{"system":"sec-edgar","filing":"0001823563-26-000002","document":"wk-form4_1772488380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000002/wk-form4_1772488380.xml","form_type":"4"}},{"id":873666,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:53:03.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":59324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units (\"PSUs\") on February 26, 2026, upon the certification by the\nBoard of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 23,411 PSUs vested on February 26, 2026, and the remaining 35,913 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":168820,"source":{"system":"sec-edgar","filing":"0001823563-26-000002","document":"wk-form4_1772488380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356326000002/wk-form4_1772488380.xml","form_type":"4"}},{"id":980049,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:44:12.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":4741,"price":47.2493,"value":224008.9313,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $47.05 to $47.51.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":109496,"source":{"system":"sec-edgar","filing":"0001823563-25-000007","document":"wk-form4_1764895449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356325000007/wk-form4_1764895449.xml","form_type":"4"}},{"id":980048,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:44:12.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":8537,"price":46.6143,"value":397946.2791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $46.04 to $47.03.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":114237,"source":{"system":"sec-edgar","filing":"0001823563-25-000007","document":"wk-form4_1764895449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356325000007/wk-form4_1764895449.xml","form_type":"4"}},{"id":980047,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:44:12.000Z","date":"2025-12-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3384,"price":46.16,"value":156205.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and\ndoes not represent a sale."}],"balance_after":122774,"source":{"system":"sec-edgar","filing":"0001823563-25-000007","document":"wk-form4_1764895449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356325000007/wk-form4_1764895449.xml","form_type":"4"}},{"id":1004699,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T21:10:12.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":41,"value":287000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024."}],"balance_after":126158,"source":{"system":"sec-edgar","filing":"0001823563-25-000005","document":"wk-form4_1762549809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000182356325000005/wk-form4_1762549809.xml","form_type":"4"}},{"id":1047649,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T21:45:15.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":5371,"price":30.11,"value":161720.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and\ndoes not represent a sale."}],"balance_after":133158,"source":{"system":"sec-edgar","filing":"0001384101-25-000122","document":"wk-form4_1757022311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000122/wk-form4_1757022311.xml","form_type":"4"}},{"id":1122497,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T21:01:32.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":5370,"price":26.74,"value":143593.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,080, 658, 906, 826 and 1,900 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of\n2,125, 1,295, 1,784, 1,626 and 3,741 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person."}],"balance_after":138529,"source":{"system":"sec-edgar","filing":"0001384101-25-000071","document":"wk-form4_1749070882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000071/wk-form4_1749070882.xml","form_type":"4"}},{"id":1214652,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:44:02.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":30200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":143899,"source":{"system":"sec-edgar","filing":"0001384101-25-000043","document":"wk-form4_1741639435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000043/wk-form4_1741639435.xml","form_type":"4"}},{"id":1235334,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:10.000Z","date":"2025-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11070,"price":34.76,"value":384793.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person is reporting the withholding of 1,080, 659, 906, 826 and 7,599 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of\n2,125, 1,296, 1,783, 1626 and 14,964 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person."}],"balance_after":113699,"source":{"system":"sec-edgar","filing":"0001384101-25-000022","document":"wk-form4_1741037397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000022/wk-form4_1741037397.xml","form_type":"4"}},{"id":1235333,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:10.000Z","date":"2025-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":11911,"price":33.84,"value":403068.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale."}],"balance_after":124769,"source":{"system":"sec-edgar","filing":"0001384101-25-000022","document":"wk-form4_1741037397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000022/wk-form4_1741037397.xml","form_type":"4"}},{"id":1235332,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:10.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":23170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units (\"PSUs\") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein."}],"balance_after":136680,"source":{"system":"sec-edgar","filing":"0001384101-25-000022","document":"wk-form4_1741037397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000022/wk-form4_1741037397.xml","form_type":"4"}},{"id":1258791,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-19T19:56:37.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":9684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760225005730/form4.xml","form_type":"4"}},{"id":1281567,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-05T21:49:23.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":527,"price":43.85,"value":23108.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024."}],"balance_after":113510,"source":{"system":"sec-edgar","filing":"0001384101-25-000006","document":"wk-form4_1738792155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000006/wk-form4_1738792155.xml","form_type":"4"}},{"id":1342630,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:59:29.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":43.2317,"value":302621.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $42.71 to $43.64.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":114037,"source":{"system":"sec-edgar","filing":"0001384101-24-000180","document":"wk-form4_1733349562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000180/wk-form4_1733349562.xml","form_type":"4"}},{"id":1342629,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:59:29.000Z","date":"2024-12-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3464,"price":44.12,"value":152831.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,077, 657, 905 and 825 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295, 1,784 and 1,626 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person."}],"balance_after":121037,"source":{"system":"sec-edgar","filing":"0001384101-24-000180","document":"wk-form4_1733349562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000180/wk-form4_1733349562.xml","form_type":"4"}},{"id":1364826,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-14T21:35:56.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":15275,"price":38.3413,"value":585663.3575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $38.04 to $38.78.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":124501,"source":{"system":"sec-edgar","filing":"0001384101-24-000166","document":"wk-form4_1731620149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000166/wk-form4_1731620149.xml","form_type":"4"}},{"id":1415341,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T00:24:45.000Z","date":"2024-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3464,"price":31.55,"value":109289.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,077, 657, 905 and 825 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,296, 1,784 and 1,626 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person."}],"balance_after":139776,"source":{"system":"sec-edgar","filing":"0001384101-24-000151","document":"wk-form4_1725491088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000151/wk-form4_1725491088.xml","form_type":"4"}},{"id":1470389,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-24T17:48:57.000Z","date":"2024-06-21","kind":"sale","planned":true,"acquired":false,"shares":260,"price":45.99,"value":11957.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."}],"balance_after":9684,"source":{"system":"sec-edgar","filing":"0001127602-24-019169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224019169/form4.xml","form_type":"4"}},{"id":1491612,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:43:25.000Z","date":"2024-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3462,"price":20.75,"value":71836.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,077, 657, 904 and 824 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295, 1,783 and 1,625 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person."}],"balance_after":143240,"source":{"system":"sec-edgar","filing":"0001384101-24-000079","document":"wk-form4_1717533798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000079/wk-form4_1717533798.xml","form_type":"4"}},{"id":1506740,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-21T18:57:34.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":964,"price":45.39,"value":43755.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."}],"balance_after":9944,"source":{"system":"sec-edgar","filing":"0001127602-24-016184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224016184/form4.xml","form_type":"4"}},{"id":1534567,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-26T16:42:28.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":42.41,"value":174983.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant."}],"balance_after":10908,"source":{"system":"sec-edgar","filing":"0001127602-24-013465","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760224013465/form4.xml","form_type":"4"}},{"id":1567726,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T20:50:02.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2189,"price":21.1,"value":46187.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person is reporting the withholding of 2,189 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,189 Performance Stock\nUnits vested on March 15, 2024 and does not represent a sale by the reporting person."}],"balance_after":146702,"source":{"system":"sec-edgar","filing":"0001384101-24-000045","document":"wk-form4_1710881393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000045/wk-form4_1710881393.xml","form_type":"4"}},{"id":1567725,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T20:50:02.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":4318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the acquisition of restricted stock units (\"RSUs\") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the\nfinancial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024.  The RSUs vested March 15, 2024."}],"balance_after":148891,"source":{"system":"sec-edgar","filing":"0001384101-24-000045","document":"wk-form4_1710881393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000045/wk-form4_1710881393.xml","form_type":"4"}},{"id":1586162,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-08T21:36:38.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":59856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":144573,"source":{"system":"sec-edgar","filing":"0001384101-24-000037","document":"wk-form4_1709933786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000037/wk-form4_1709933786.xml","form_type":"4"}},{"id":1594694,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T22:28:19.000Z","date":"2024-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6112,"price":24,"value":146688.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,190, 726, 900 and 3,296 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,296, 1,784 and 6,503 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person."}],"balance_after":84717,"source":{"system":"sec-edgar","filing":"0001384101-24-000026","document":"wk-form4_1709677679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000026/wk-form4_1709677679.xml","form_type":"4"}},{"id":1721231,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T21:44:50.000Z","date":"2023-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1800,"price":26.54,"value":47772.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 735, 448 and 617 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295 and 1,783 Restricted Stock Units granted on July 19, 2021, March 3, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person."}],"balance_after":90829,"source":{"system":"sec-edgar","filing":"0001384101-23-000169","document":"wk-form4_1701812679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000169/wk-form4_1701812679.xml","form_type":"4"}},{"id":1786803,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T20:30:45.000Z","date":"2023-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3652,"price":26.7,"value":97508.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 735, 449 and 2,468 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,296 and 7,135 Restricted Stock Units granted on July 19, 2021, March 3, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 527 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan."}],"balance_after":92629,"source":{"system":"sec-edgar","filing":"0001384101-23-000147","document":"wk-form4_1694032228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000147/wk-form4_1694032228.xml","form_type":"4"}},{"id":1864925,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-06T20:48:59.000Z","date":"2023-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1183,"price":26.72,"value":31609.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 735 and 448 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125 and 1,295 Restricted Stock Units granted on July 19, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person."}],"balance_after":95754,"source":{"system":"sec-edgar","filing":"0001384101-23-000082","document":"wf-form4_168608452858125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000082/wf-form4_168608452858125.xml","form_type":"4"}},{"id":1884159,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T17:55:41.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 18, 2023, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2024 annual meeting."}],"balance_after":6782,"source":{"system":"sec-edgar","filing":"0001127602-23-016351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760223016351/form4.xml","form_type":"4"}},{"id":1960687,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-10T00:09:43.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":42956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on March 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":42956,"derivative":{"exercise_price":23.73,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":42956},"source":{"system":"sec-edgar","filing":"0001384101-23-000035","document":"wf-form4_167840697137017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000035/wf-form4_167840697137017.xml","form_type":"4"}},{"id":1960686,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-10T00:09:43.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2023 vest 25% on March 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":96937,"source":{"system":"sec-edgar","filing":"0001384101-23-000035","document":"wf-form4_167840697137017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000035/wf-form4_167840697137017.xml","form_type":"4"}},{"id":1972195,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-04T01:11:19.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":2726,"price":24.1,"value":65696.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 867 and 1,859 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125 and 5,182 Restricted Stock Units granted on July 19, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 651 shares of common stock purchased on January 31, 2023  pursuant to the Veracyte, Inc. Employee Stock Purchase Plan."}],"balance_after":70923,"source":{"system":"sec-edgar","filing":"0001384101-23-000030","document":"wf-form4_167789226146411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000030/wf-form4_167789226146411.xml","form_type":"4"}},{"id":2094221,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-06T22:14:12.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":735,"price":29.14,"value":21417.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 735 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125 Restricted Stock Units granted on July 19, 2021 and does not represent a sale by the reporting person."}],"balance_after":72998,"source":{"system":"sec-edgar","filing":"0001384101-22-000153","document":"wf-form4_167036483697035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000153/wf-form4_167036483697035.xml","form_type":"4"}},{"id":2164006,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-07T20:56:29.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":3023,"price":19.18,"value":57981.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 3,023 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 8,500 Restricted Stock Units granted on July 19, 2021 and does not represent a sale by the reporting person."}],"balance_after":73733,"source":{"system":"sec-edgar","filing":"0001384101-22-000129","document":"wf-form4_166258416622084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000129/wf-form4_166258416622084.xml","form_type":"4"}},{"id":2190562,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:17:21.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":36496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":36496,"derivative":{"exercise_price":27.9,"expiration_date":"2032-08-05","underlying":"Stock Option (right to buy)","underlying_shares":36496},"source":{"system":"sec-edgar","filing":"0001384101-22-000115","document":"wf-form4_166007981918123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000115/wf-form4_166007981918123.xml","form_type":"4"}},{"id":2190561,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:17:21.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":21404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 624 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan."}],"balance_after":76756,"source":{"system":"sec-edgar","filing":"0001384101-22-000115","document":"wf-form4_166007981918123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000115/wf-form4_166007981918123.xml","form_type":"4"}},{"id":2252789,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-27T16:40:52.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 26, 2022, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2023 annual meeting."}],"balance_after":4370,"source":{"system":"sec-edgar","filing":"0001127602-22-015884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000112760222015884/form4.xml","form_type":"4"}},{"id":2347279,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T21:40:31.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":37773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":37773,"derivative":{"exercise_price":26.02,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":37773},"source":{"system":"sec-edgar","filing":"0001384101-22-000050","document":"wf-form4_164668921354091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000050/wf-form4_164668921354091.xml","form_type":"4"}},{"id":2347278,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:40:31.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":20728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":54728,"source":{"system":"sec-edgar","filing":"0001384101-22-000050","document":"wf-form4_164668921354091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000050/wf-form4_164668921354091.xml","form_type":"4"}},{"id":2629033,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-20T20:51:17.000Z","date":"2021-07-19","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on July 19, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":67000,"derivative":{"exercise_price":36.59,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001384101-21-000127","document":"wf-form4_162681424157518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000127/wf-form4_162681424157518.xml","form_type":"4"}},{"id":2629032,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-20T20:51:17.000Z","date":"2021-07-19","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (RSUs) awarded on July 19, 2021, which vest 25% on September 2, 2022 and 1/16 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001384101-21-000127","document":"wf-form4_162681424157518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000127/wf-form4_162681424157518.xml","form_type":"4"}},{"id":2654759,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-25T20:02:55.000Z","date":"2021-06-24","kind":"exercise","acquired":false,"shares":16727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on June 3, 2020 and then in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":77745,"derivative":{"exercise_price":6.25,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":16727},"source":{"system":"sec-edgar","filing":"0001484612-21-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000035/edgardoc.xml","form_type":"4"}},{"id":2654758,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-25T20:02:55.000Z","date":"2021-06-24","kind":"sale","acquired":false,"shares":16727,"price":50.7188,"value":848373.3676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $50.32 to $51.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001484612-21-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000035/edgardoc.xml","form_type":"4"}},{"id":2654757,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-25T20:02:55.000Z","date":"2021-06-24","kind":"exercise","acquired":true,"shares":16727,"price":6.25,"value":104543.75,"ownership":{"direct":true},"balance_after":30324,"source":{"system":"sec-edgar","filing":"0001484612-21-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000035/edgardoc.xml","form_type":"4"}},{"id":2658391,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T19:45:27.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":1950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs) that vest 1/3 on each of the first, second and third anniversary of the grant date."}],"balance_after":1950,"source":{"system":"sec-edgar","filing":"0001562180-21-004431","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531048/000156218021004431/primarydocument.xml","form_type":"4"}},{"id":2695097,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-26T21:18:03.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":16727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests 25% on June 3, 2020 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":94472,"derivative":{"exercise_price":6.25,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":16727},"source":{"system":"sec-edgar","filing":"0001484612-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000010/edgardoc.xml","form_type":"4"}},{"id":2695096,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T21:18:03.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":16727,"price":45.1088,"value":754534.8976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $44.61 to $45.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001484612-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000010/edgardoc.xml","form_type":"4"}},{"id":2695095,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T21:18:03.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":16727,"price":6.25,"value":104543.75,"ownership":{"direct":true},"balance_after":30324,"source":{"system":"sec-edgar","filing":"0001484612-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461221000010/edgardoc.xml","form_type":"4"}},{"id":2737148,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-28T22:43:25.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":16727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on June 3, 2020, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":111199,"derivative":{"exercise_price":6.25,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":16727},"source":{"system":"sec-edgar","filing":"0000905148-21-000407","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000090514821000407/form4.xml","form_type":"4"}},{"id":2737147,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-28T22:43:25.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":8228,"price":56.8857,"value":468055.5396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $56.79 to $57.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3)."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0000905148-21-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000090514821000407/form4.xml","form_type":"4"}},{"id":2737146,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-28T22:43:25.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":8499,"price":56.3309,"value":478756.3191,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $55.79 to $56.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":21825,"source":{"system":"sec-edgar","filing":"0000905148-21-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000090514821000407/form4.xml","form_type":"4"}},{"id":2737145,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-28T22:43:25.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":16727,"price":6.25,"value":104543.75,"ownership":{"direct":true},"balance_after":30324,"source":{"system":"sec-edgar","filing":"0000905148-21-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000090514821000407/form4.xml","form_type":"4"}},{"id":2769268,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-29T11:00:34.000Z","date":"2021-03-25","kind":"exercise","acquired":false,"shares":16727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This Form 4 corrects the exercise price previously reported as $6.24 on the Form 3 filed on September 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on June 3, 2020, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":127926,"derivative":{"exercise_price":6.25,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":16727},"source":{"system":"sec-edgar","filing":"0001140361-21-010380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121010380/form4.xml","form_type":"4"}},{"id":2769267,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-29T11:00:34.000Z","date":"2021-03-25","kind":"sale","acquired":false,"shares":13135,"price":50.1639,"value":658902.8265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $49.68 to $51.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3)."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001140361-21-010380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121010380/form4.xml","form_type":"4"}},{"id":2769266,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-29T11:00:34.000Z","date":"2021-03-25","kind":"sale","acquired":false,"shares":3592,"price":49.1133,"value":176414.9736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":26732,"source":{"system":"sec-edgar","filing":"0001140361-21-010380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121010380/form4.xml","form_type":"4"}},{"id":2769265,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-29T11:00:34.000Z","date":"2021-03-25","kind":"exercise","acquired":true,"shares":16727,"price":6.25,"value":104543.75,"ownership":{"direct":true},"balance_after":30324,"source":{"system":"sec-edgar","filing":"0001140361-21-010380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121010380/form4.xml","form_type":"4"}},{"id":2779199,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T19:17:59.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":27037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This Form 4 amendment is being filed to correct the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":27037,"derivative":{"exercise_price":50.01,"expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":27037},"source":{"system":"sec-edgar","filing":"0001140361-21-009053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121009053/form4.xml","form_type":"4/A","original_submission_date":"2021-03-17"}},{"id":2782233,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T01:10:25.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":27037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":27037,"derivative":{"exercise_price":25.89,"expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":27037},"source":{"system":"sec-edgar","filing":"0001140361-21-008971","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121008971/form4.xml","form_type":"4"}},{"id":2782232,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-18T01:10:25.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":13597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on March 15, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on March 15, 2022, then quarterly over three years on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001140361-21-008971","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000114036121008971/form4.xml","form_type":"4"}}]}